Materialise is to pursue a further itemizing of its extraordinary shares on Euronext Brussels to enrich its current Nasdaq itemizing of its American depositary shares (ADSs) representing extraordinary shares, and to launch an ADS buyback program.
The itemizing is designed to additional improve Materialise’s profile and develop its investor base. Whereas Materialise says the corporate’s Nasdaq itemizing stays integral to the corporate’s international technique, a further itemizing will enable traders to carry and deal in shares on Euronext (and grow to be shareholders of the corporate) in addition to to carry and deal in ADSs on Nasdaq.
This plan, per Materialise, represents a ‘proactive step to attach its heritage with its international ambitions,’ making certain the corporate’s skill to ‘drive progress and ship significant influence in a number of sectors.’ The extra itemizing might additionally give Materialise entry to further caputre if wanted sooner or later, create further liquidity choices for shareholders, and open up the choice to provoke ADS and/or share buyback applications.
The itemizing is anticipated to occur on or round November 20, 2025, however no shares might be provided and no capital might be raised in reference to the itemizing of the corporate’s shares on Euronext Brussels. Materialise has, nevertheless, authorized an ADS buyback program price as much as 30 million EUR over Nasdaq. This buyback program is topic to and with impact from not sooner than (i) the publication within the Annexes to the Belgian State Gazette of the approval by the corporate’s common shareholders’ assembly to be held on November 14, 2025 of the authorisation to the Board of Administrators to purchase again shares and (ii) the completion of the itemizing of the corporate’s shares on Euronext Brussels. Repurchases are anticipated to be initiated by no later than January 2026 and executed inside 12 months following initiation. Nevertheless, the initiation, timing and quantity of repurchases pursuant to this system will depend upon quite a lot of components together with market situations. Based mostly on the closing worth of the Firm’s ADSs on Nasdaq on October 28, 2025, this quantity represented roughly 6.1 million ADSs.
Such variety of ADSs will fluctuate relying on share worth actions. The corporate is below no obligation to amass any quantity of ADSs. The ADS buyback program could be applied in accordance with market apply and in compliance with the relevant legislation and rules. To this finish, the corporate expects an unbiased monetary middleman could be appointed to repurchase on the idea of a discretionary mandate. In the course of the ADS buyback program, the corporate would often publish press releases with updates on the progress made (if any) as required by legislation. This data would even be accessible on the investor relations pages of Materialise’s web site below the Information part (https://traders.materialise.com/information). The corporate’s present intention is to carry any ADSs acquired (or underlying shares) in treasury and will sooner or later use these as a consideration for mergers and acquisitions, aligning with Materialise’s imaginative and prescient for scaling its operations in key sectors corresponding to healthcare, aerospace, and protection, and/or in any other case eliminate these ADSs or shares, together with for potential share supply commitments below future fairness incentive plans. This system could be executed below the powers proposed to be granted on the extraordinary common assembly of shareholders to be held on November 14, 2025.
“At Materialise, we’re happy with our heritage and our international ambitions,” stated Brigitte de Vet, CEO of Materialise. “Pursuing a further itemizing on Euronext Brussels is a pure step in broadening our investor base whereas persevering with to construct on our international progress technique. By aligning our roots with our imaginative and prescient, we intention to create long-term worth for shareholders and help innovation throughout industries from healthcare to aerospace, and past.”
